JAX, Frasergen announce cancer genomics facility in Hubei Province, China

(Jackson Laboratory) The Jackson Laboratory, a nonprofit US-based biomedical research institution, in conjunction with the Chinese company Wuhan Frasergen Bioinformatics Co., Ltd., announced the creation of a facility in Wuhan, China, that will enable researchers there to investigate cancers and their response to novel drugs and immunotherapies using the Laboratory's innovative cancer tools according to a memorandum of understanding announced in Wuhan on June 7.